Ameridose Closure Extended Six Weeks
The Westborough firm shares owners with the Framingham company tied to the meningitis outbreak.
State health officials have extended the closing of Ameridose for six weeks, the Boston Globe reports.
The Globe reports the state Department of Public Health said in a statement that the Westborough drug company will continue undergoing a joint state and federal investigation regarding “unsanitary conditions and questionable sterility practices at the facility."
Ameridose shares owners with the New England Compounding Center, a specialty pharmacy in Framingham linked to the national deadly meningitis outbreak.
In November, federal Food and Drug Administration inspectors reported seeing insects and a bird while inspecting Ameridose.